Synapse - Ayca Gucalp

Results (113)

First-in-human study of FAZ053, an anti-PD-L1 mAb, alone and in combination with spartalizumab, an anti-PD-1 mAb, in patients with advanced malignancies

Meeting Abstract

Janku, F.; Tan, D.; Martin-Liberal, J.; Takahashi, S.; Geva, R.; Gucalp, A.; Chen, X.; Subramanian, K.; Mataraza, J.; Wheler, J.; more...
Journal for ImmunoTherapy of Cancer (2018)

Fulltext@MSK | Save

Safety and tolerability of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR+) triple negative breast cancer

Meeting Abstract

Lyons, T.; Gucalp, A.; Arumov, A.; Patil, S.; Edelweiss, M.; Gorsky, M.; Troso-Sandoval, T. A.; Bromberg, J.; Sanford, R. A.; Iyengar, N. M.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Phase 1 study of seviteronel, a selective CYP17 lyase and androgen receptor inhibitor, in women with estrogen receptor-positive or triple-negative breast cancer

Journal Article

Bardia, A.; Gucalp, A.; DaCosta, N.; Gabrail, N.; Danso, M.; Ali, H.; Blackwell, K. L.; Carey, L. A.; Eisner, J. R.; Baskin-Bey, E. S.; more...
Breast Cancer Research and Treatment (2018)

Fulltext@MSK | Save

A randomized multicenter phase II study of docosahexaenoic acid in patients with a history of breast cancer, premalignant lesions, or benign breast disease

Journal Article

Gucalp, A.; Zhou, X. K.; Cook, E. D.; Garber, J. E.; Crew, K. D.; Nangia, J. R.; Bhardwaj, P.; Giri, D. D.; Elemento, O.; Verma, A.; more...
Cancer Prevention Research (2018)

Fulltext@MSK | Save

Leptin regulation of the p53-HIF1α/PKM2-aromatase axis in breast adipose stromal cells: A novel mechanism for the obesity-breast cancer link

Journal Article

Zahid, H.; Subbaramaiah, K.; Iyengar, N. M.; Zhou, X. K.; Chen, I. C.; Bhardwaj, P.; Gucalp, A.; Morrow, M.; Hudis, C. A.; Dannenberg, A. J.; more...
International Journal of Obesity (2018)

Fulltext@MSK | Save

The microbial flora of taxane therapy–associated nail disease in cancer patients

Journal Article

Virgen, C. A.; Belum, V. R.; Kamboj, M.; Goldfarb, S. B.; Blinder, V. S.; Gucalp, A.; Lacouture, M. E.
Journal of the American Academy of Dermatology (2018)

Fulltext@MSK | Save

Enzalutamide for the treatment of androgen receptor-expressing triple-negative breast cancer

Journal Article

Traina, T. A.; Miller, K.; Yardley, D. A.; Eakle, J.; Schwartzberg, L. S.; O'Shaughnessy, J.; Gradishar, W.; Schmid, P.; Winer, E.; Kelly, C.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Obesity and adipose inflammation in men with breast cancer

Meeting Abstract

Williams, S.; Parrish, J. C.; Zhou, X. K.; Wang, H.; Dierickx, A.; Gucalp, A.; Dannenberg, A. J.; Iyengar, N. M.
Cancer Research (2018)

Fulltext@MSK | Save

Results from a randomized placebo-controlled phase 2 trial evaluating exemestane ± enzalutamide in patients with hormone receptor-positive breast cancer

Meeting Abstract

Krop, I.; Abramson, V.; Colleoni, M.; Traina, T.; Holmes, F.; Estevez, L.; Hart, L.; Awada, A.; Zamagni, C.; Morris, P.; more...
Cancer Research (2018)

Fulltext@MSK | Save

Phase I/II trial of palbociclib in combination with bicalutamide for the treatment of androgen receptor (AR)+ metastatic breast cancer (MBC)

Meeting Abstract

Gucalp, A.; Edelweiss, M.; Patil, S.; Gounder, M. M.; Feigin, K. N.; Corben, A.; Arumov, A.; Traina, T. A.
Cancer Research (2018)

Fulltext@MSK | Save